Jazz Pharmaceuticals PLC Equity-NMS: JAZZ

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$120.82
Open :$116.48
Today's high :$117.11
Today's low :$109.76
52W low :$99.06
52W high :$148.0568
EPS(TTM): :8.65
Shares O/S :60.73 M
Market cap :6.68 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Jazz Pharmaceuticals PLC $110.04 -8.26% 13.97 6.68B

Frequently Asked Questions

What is the share price of Jazz Pharmaceuticals PLC today?

Jazz Pharmaceuticals PLC (JAZZ) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Jazz Pharmaceuticals PLC

Jazz Pharmaceuticals PLC is a biotechnology company. The Company is engaged in developing medicines for people with serious diseases. The Company’s lead marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Xyrem (sodium oxybate) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), Zepzelca (lurbinectedin), Defitelio (defibrotide sodium) AND Vyxeos (daunorubicin and cytarabine) liposome for injection. The Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution product is for the treatment of cataplexy or excessive daytime sleepiness (EDS), in patients with narcolepsy seven years of age and older. The Xyrem (sodium oxybate) oral solution product is for the treatment of cataplexy or EDS in patients with narcolepsy seven years of age and older. The Defitelio (defibrotide sodium) product is for the treatment of hepatic veno-occlusive disease (VOD).